TY - JOUR
T1 - Improving Reporting of Clinical Studies Using the POSEIDON Criteria
T2 - POSORT Guidelines
AU - Esteves, Sandro C.
AU - Conforti, Alessandro
AU - Sunkara, Sesh K.
AU - Carbone, Luigi
AU - Picarelli, Silvia
AU - Vaiarelli, Alberto
AU - Cimadomo, Danilo
AU - Rienzi, Laura
AU - Ubaldi, Filippo Maria
AU - Zullo, Fulvio
AU - Andersen, Claus Yding
AU - Orvieto, Raoul
AU - Humaidan, Peter
AU - Alviggi, Carlo
N1 - Publisher Copyright:
© Copyright © 2021 Esteves, Conforti, Sunkara, Carbone, Picarelli, Vaiarelli, Cimadomo, Rienzi, Ubaldi, Zullo, Andersen, Orvieto, Humaidan and Alviggi.
PY - 2021/3/19
Y1 - 2021/3/19
N2 - The POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) criteria were developed to help clinicians identify and classify low-prognosis patients undergoing assisted reproductive technology (ART) and provide guidance for possible therapeutic strategies to overcome infertility. Since its introduction, the number of published studies using the POSEIDON criteria has increased steadily. However, a critical analysis of existing evidence indicates inconsistent and incomplete reporting of critical outcomes. Therefore, we developed guidelines to help researchers improve the quality of reporting in studies applying the POSEIDON criteria. We also discuss the advantages of using the POSEIDON criteria in ART clinical studies and elaborate on possible study designs and critical endpoints. Our ultimate goal is to advance the knowledge concerning the clinical use of the POSEIDON criteria to patients, clinicians, and the infertility community.
AB - The POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) criteria were developed to help clinicians identify and classify low-prognosis patients undergoing assisted reproductive technology (ART) and provide guidance for possible therapeutic strategies to overcome infertility. Since its introduction, the number of published studies using the POSEIDON criteria has increased steadily. However, a critical analysis of existing evidence indicates inconsistent and incomplete reporting of critical outcomes. Therefore, we developed guidelines to help researchers improve the quality of reporting in studies applying the POSEIDON criteria. We also discuss the advantages of using the POSEIDON criteria in ART clinical studies and elaborate on possible study designs and critical endpoints. Our ultimate goal is to advance the knowledge concerning the clinical use of the POSEIDON criteria to patients, clinicians, and the infertility community.
KW - ART calculator
KW - Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number (POSEIDON) criteria
KW - assisted reproductive technology
KW - guidelines
KW - infertility
KW - low prognosis
KW - ovarian stimulation
KW - poor response
UR - http://www.scopus.com/inward/record.url?scp=85103563710&partnerID=8YFLogxK
U2 - 10.3389/fendo.2021.587051
DO - 10.3389/fendo.2021.587051
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 33815269
AN - SCOPUS:85103563710
SN - 1664-2392
VL - 12
JO - Frontiers in Endocrinology
JF - Frontiers in Endocrinology
M1 - 587051
ER -